PMDA drug package insert
ハイヤスミンA
PMDA OTC drug · 福地製薬（株） · package insert Sep 12, 2026
Key facts
| Brand names | ハイヤスミンA |
|---|---|
| Companies | 製造販売元／大昭製薬（株）,販売会社／福地製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 催眠鎮静薬 |
| Package insert date | Sep 12, 2026 |
| PMDA document key | 431011_K0710000001 |
| PMDA company code | 431011 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: